European Medicines Agency (EMA) has recommended granting a marketing authorisation for Evusheld, developed by AstraZeneca, for the prevention of COVID-19 in adults and adolescents...
The European Union's drug regulator- EMA- on Thursday approved Pfizer's antiviral COVID-19 pill for treating adults at risk of severe illness, as the region...
The EU's medicines watchdog said on Wednesday two jabs by approved vaccine makers were "vital" to provide maximum protection against the highly infectious coronavirus...
The vaccine was "well tolerated" in children and there were no "major concerns" in terms of side effects, the Amsterdam-based European Medicines Agency said.
EMA did not name the company it expects to file the application, but Pfizer and BioNTEch are the most advanced in the regulatory process among the three companies
EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for Ervebo, the first vaccine for Ebola virus